| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_73ee0bacab5a7576a6a3244747f6ea99 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18 |
| filingDate |
1975-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1977-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57dfc1c98ec2e9f184249dbd4f82b0b6 |
| publicationDate |
1977-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4034112-A |
| titleOfInvention |
Ethanolamine derivatives having β-adrenergic blocking activity |
| abstract |
Novel 1-aryl-2-amidoalkylaminoethanol derivatives, processes for their manufacture, pharmaceutical compositions containing them and methods of using them in the treatment of heart diseases. The compounds possess beta -adrenergic blocking activity. Representative of the compounds disclosed is 1-phenyl-2-(1,1-dimethyl-2-phenylacetamidoethyl)aminoethanol. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4140713-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4764361-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4618711-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4217305-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4086357-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4115409-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4117157-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0006298-A1 |
| priorityDate |
1973-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |